Skip to main content
. 2022 Feb 21;14(2):461. doi: 10.3390/pharmaceutics14020461

Table 3.

Drug treatments and dosages at patient recruitment.

Gender Treatments Daily Dose (mg/day)
Female (19%) Rac-methadone 55 ± 10 mg/day
Levomethadone 45.11 ± 6.5 mg/day
Buprenorphine/naloxone 4 ± 2.62 mg/day
Male (81%) Rac-methadone 57.21 ± 10.88 mg/day
Levomethadone 28.75 ± 7.5 mg/day *°
Buprenorphine/naloxone 8 ± 3.62 mg/day

* Data significantly different vs. rac-methadone group and ° female group.